Global Chinese Patent Medicine for Bones and Muscles Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Page: 130
Published Date: 09 Sep 2024
Category: Medical Care
PDF Download
Get FREE Sample
Customize Request
- Description
- Table of Contents
- Table of Figures
- Research Methodology
- Companies Mentioned
- Related Reports
- Product Tags
Description
Chinese patent medicine are herbal medicines in Traditional Chinese medicine, modernized into a ready-to-use form such as tablets, oral solutions or dry suspensions, as opposed to herbs that require cooking (hot water extraction). This report focus on Chinese Patent Medicine for Bones and Muscles.
According to our (Global Info Research) latest study, the global Chinese Patent Medicine for Bones and Muscles market size was valued at US$ 2975 million in 2023 and is forecast to a readjusted size of USD 4221 million by 2030 with a CAGR of 5.0% during review period.
As an indispensable part of Traditional Chinese medicine (TCM), Chinese patent medicines have played an important role in preventing and treating diseases in China. Since they are easy to use, easy to store, and cost-effective, Chinese patent medicines have been generally accepted and widely used in Chinese clinical practice as a vital medical resource. In recent years, as TCM has developed and it has been accepted around the world, many Chinese patent medicine companies have gained international market access and successfully registered several Chinese patent medicines as over-the-counter (OTC) or prescription drugs in regions and countries that primarily use Western medicine such as the EU, Russia, Canada, Singapore, and Vietnam. Moreover, several Chinese patent medicines have been obtained the US Food and Drug Administration (FDA) approval conducting phase II or III clinical trials in the US.
This report is a detailed and comprehensive analysis for global Chinese Patent Medicine for Bones and Muscles market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Chinese Patent Medicine for Bones and Muscles market size and forecasts, in consumption value ($ Million), 2019-2030
Global Chinese Patent Medicine for Bones and Muscles market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Chinese Patent Medicine for Bones and Muscles market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Chinese Patent Medicine for Bones and Muscles market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Chinese Patent Medicine for Bones and Muscles
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Chinese Patent Medicine for Bones and Muscles market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zhongheng Group, Fangsheng Pharmaceutical, Yunnan Baiyao Group, Beijing TRT Group, Pien Tze Huang Pharmaceutical, BaiYunShan Pharmaceutical, China Resources Sanjiu, Yiling Pharmaceutical, Jumpcan Pharmaceutical, Tasly Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Chinese Patent Medicine for Bones and Muscles market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Chinese Patent Medicine for Bones and Muscles market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Oral
Topical
Others
Market segment by Application
Hospital
Pharmacy
Others
Market segment by players, this report covers
Zhongheng Group
Fangsheng Pharmaceutical
Yunnan Baiyao Group
Beijing TRT Group
Pien Tze Huang Pharmaceutical
BaiYunShan Pharmaceutical
China Resources Sanjiu
Yiling Pharmaceutical
Jumpcan Pharmaceutical
Tasly Group
Buchang Pharmaceutical
Sunflower Pharmaceutical
Ginwa Enterprise
KPC Pharmaceutical
Jiangsu Kanion Pharmaceutical
Xintian Pharmaceutical
Henan Lingrui Pharmaceutical
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Chinese Patent Medicine for Bones and Muscles product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Chinese Patent Medicine for Bones and Muscles, with revenue, gross margin, and global market share of Chinese Patent Medicine for Bones and Muscles from 2019 to 2024.
Chapter 3, the Chinese Patent Medicine for Bones and Muscles competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Chinese Patent Medicine for Bones and Muscles market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Chinese Patent Medicine for Bones and Muscles.
Chapter 13, to describe Chinese Patent Medicine for Bones and Muscles research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Chinese Patent Medicine for Bones and Muscles by Type
1.3.1 Overview: Global Chinese Patent Medicine for Bones and Muscles Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Chinese Patent Medicine for Bones and Muscles Consumption Value Market Share by Type in 2023
1.3.3 Oral
1.3.4 Topical
1.3.5 Others
1.4 Global Chinese Patent Medicine for Bones and Muscles Market by Application
1.4.1 Overview: Global Chinese Patent Medicine for Bones and Muscles Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Pharmacy
1.4.4 Others
1.5 Global Chinese Patent Medicine for Bones and Muscles Market Size & Forecast
1.6 Global Chinese Patent Medicine for Bones and Muscles Market Size and Forecast by Region
1.6.1 Global Chinese Patent Medicine for Bones and Muscles Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Chinese Patent Medicine for Bones and Muscles Market Size by Region, (2019-2030)
1.6.3 North America Chinese Patent Medicine for Bones and Muscles Market Size and Prospect (2019-2030)
1.6.4 Europe Chinese Patent Medicine for Bones and Muscles Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Chinese Patent Medicine for Bones and Muscles Market Size and Prospect (2019-2030)
1.6.6 South America Chinese Patent Medicine for Bones and Muscles Market Size and Prospect (2019-2030)
1.6.7 Middle East & Africa Chinese Patent Medicine for Bones and Muscles Market Size and Prospect (2019-2030)
2 Company Profiles
2.1 Zhongheng Group
2.1.1 Zhongheng Group Details
2.1.2 Zhongheng Group Major Business
2.1.3 Zhongheng Group Chinese Patent Medicine for Bones and Muscles Product and Solutions
2.1.4 Zhongheng Group Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Zhongheng Group Recent Developments and Future Plans
2.2 Fangsheng Pharmaceutical
2.2.1 Fangsheng Pharmaceutical Details
2.2.2 Fangsheng Pharmaceutical Major Business
2.2.3 Fangsheng Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Solutions
2.2.4 Fangsheng Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Fangsheng Pharmaceutical Recent Developments and Future Plans
2.3 Yunnan Baiyao Group
2.3.1 Yunnan Baiyao Group Details
2.3.2 Yunnan Baiyao Group Major Business
2.3.3 Yunnan Baiyao Group Chinese Patent Medicine for Bones and Muscles Product and Solutions
2.3.4 Yunnan Baiyao Group Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Yunnan Baiyao Group Recent Developments and Future Plans
2.4 Beijing TRT Group
2.4.1 Beijing TRT Group Details
2.4.2 Beijing TRT Group Major Business
2.4.3 Beijing TRT Group Chinese Patent Medicine for Bones and Muscles Product and Solutions
2.4.4 Beijing TRT Group Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Beijing TRT Group Recent Developments and Future Plans
2.5 Pien Tze Huang Pharmaceutical
2.5.1 Pien Tze Huang Pharmaceutical Details
2.5.2 Pien Tze Huang Pharmaceutical Major Business
2.5.3 Pien Tze Huang Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Solutions
2.5.4 Pien Tze Huang Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Pien Tze Huang Pharmaceutical Recent Developments and Future Plans
2.6 BaiYunShan Pharmaceutical
2.6.1 BaiYunShan Pharmaceutical Details
2.6.2 BaiYunShan Pharmaceutical Major Business
2.6.3 BaiYunShan Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Solutions
2.6.4 BaiYunShan Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 BaiYunShan Pharmaceutical Recent Developments and Future Plans
2.7 China Resources Sanjiu
2.7.1 China Resources Sanjiu Details
2.7.2 China Resources Sanjiu Major Business
2.7.3 China Resources Sanjiu Chinese Patent Medicine for Bones and Muscles Product and Solutions
2.7.4 China Resources Sanjiu Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 China Resources Sanjiu Recent Developments and Future Plans
2.8 Yiling Pharmaceutical
2.8.1 Yiling Pharmaceutical Details
2.8.2 Yiling Pharmaceutical Major Business
2.8.3 Yiling Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Solutions
2.8.4 Yiling Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Yiling Pharmaceutical Recent Developments and Future Plans
2.9 Jumpcan Pharmaceutical
2.9.1 Jumpcan Pharmaceutical Details
2.9.2 Jumpcan Pharmaceutical Major Business
2.9.3 Jumpcan Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Solutions
2.9.4 Jumpcan Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Jumpcan Pharmaceutical Recent Developments and Future Plans
2.10 Tasly Group
2.10.1 Tasly Group Details
2.10.2 Tasly Group Major Business
2.10.3 Tasly Group Chinese Patent Medicine for Bones and Muscles Product and Solutions
2.10.4 Tasly Group Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Tasly Group Recent Developments and Future Plans
2.11 Buchang Pharmaceutical
2.11.1 Buchang Pharmaceutical Details
2.11.2 Buchang Pharmaceutical Major Business
2.11.3 Buchang Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Solutions
2.11.4 Buchang Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Buchang Pharmaceutical Recent Developments and Future Plans
2.12 Sunflower Pharmaceutical
2.12.1 Sunflower Pharmaceutical Details
2.12.2 Sunflower Pharmaceutical Major Business
2.12.3 Sunflower Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Solutions
2.12.4 Sunflower Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Sunflower Pharmaceutical Recent Developments and Future Plans
2.13 Ginwa Enterprise
2.13.1 Ginwa Enterprise Details
2.13.2 Ginwa Enterprise Major Business
2.13.3 Ginwa Enterprise Chinese Patent Medicine for Bones and Muscles Product and Solutions
2.13.4 Ginwa Enterprise Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Ginwa Enterprise Recent Developments and Future Plans
2.14 KPC Pharmaceutical
2.14.1 KPC Pharmaceutical Details
2.14.2 KPC Pharmaceutical Major Business
2.14.3 KPC Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Solutions
2.14.4 KPC Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 KPC Pharmaceutical Recent Developments and Future Plans
2.15 Jiangsu Kanion Pharmaceutical
2.15.1 Jiangsu Kanion Pharmaceutical Details
2.15.2 Jiangsu Kanion Pharmaceutical Major Business
2.15.3 Jiangsu Kanion Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Solutions
2.15.4 Jiangsu Kanion Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Jiangsu Kanion Pharmaceutical Recent Developments and Future Plans
2.16 Xintian Pharmaceutical
2.16.1 Xintian Pharmaceutical Details
2.16.2 Xintian Pharmaceutical Major Business
2.16.3 Xintian Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Solutions
2.16.4 Xintian Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Xintian Pharmaceutical Recent Developments and Future Plans
2.17 Henan Lingrui Pharmaceutical
2.17.1 Henan Lingrui Pharmaceutical Details
2.17.2 Henan Lingrui Pharmaceutical Major Business
2.17.3 Henan Lingrui Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Solutions
2.17.4 Henan Lingrui Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Henan Lingrui Pharmaceutical Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Chinese Patent Medicine for Bones and Muscles Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Chinese Patent Medicine for Bones and Muscles by Company Revenue
3.2.2 Top 3 Chinese Patent Medicine for Bones and Muscles Players Market Share in 2023
3.2.3 Top 6 Chinese Patent Medicine for Bones and Muscles Players Market Share in 2023
3.3 Chinese Patent Medicine for Bones and Muscles Market: Overall Company Footprint Analysis
3.3.1 Chinese Patent Medicine for Bones and Muscles Market: Region Footprint
3.3.2 Chinese Patent Medicine for Bones and Muscles Market: Company Product Type Footprint
3.3.3 Chinese Patent Medicine for Bones and Muscles Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Chinese Patent Medicine for Bones and Muscles Consumption Value and Market Share by Type (2019-2024)
4.2 Global Chinese Patent Medicine for Bones and Muscles Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
5.1 Global Chinese Patent Medicine for Bones and Muscles Consumption Value Market Share by Application (2019-2024)
5.2 Global Chinese Patent Medicine for Bones and Muscles Market Forecast by Application (2025-2030)
6 North America
6.1 North America Chinese Patent Medicine for Bones and Muscles Consumption Value by Type (2019-2030)
6.2 North America Chinese Patent Medicine for Bones and Muscles Market Size by Application (2019-2030)
6.3 North America Chinese Patent Medicine for Bones and Muscles Market Size by Country
6.3.1 North America Chinese Patent Medicine for Bones and Muscles Consumption Value by Country (2019-2030)
6.3.2 United States Chinese Patent Medicine for Bones and Muscles Market Size and Forecast (2019-2030)
6.3.3 Canada Chinese Patent Medicine for Bones and Muscles Market Size and Forecast (2019-2030)
6.3.4 Mexico Chinese Patent Medicine for Bones and Muscles Market Size and Forecast (2019-2030)
7 Europe
7.1 Europe Chinese Patent Medicine for Bones and Muscles Consumption Value by Type (2019-2030)
7.2 Europe Chinese Patent Medicine for Bones and Muscles Consumption Value by Application (2019-2030)
7.3 Europe Chinese Patent Medicine for Bones and Muscles Market Size by Country
7.3.1 Europe Chinese Patent Medicine for Bones and Muscles Consumption Value by Country (2019-2030)
7.3.2 Germany Chinese Patent Medicine for Bones and Muscles Market Size and Forecast (2019-2030)
7.3.3 France Chinese Patent Medicine for Bones and Muscles Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Chinese Patent Medicine for Bones and Muscles Market Size and Forecast (2019-2030)
7.3.5 Russia Chinese Patent Medicine for Bones and Muscles Market Size and Forecast (2019-2030)
7.3.6 Italy Chinese Patent Medicine for Bones and Muscles Market Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Chinese Patent Medicine for Bones and Muscles Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Chinese Patent Medicine for Bones and Muscles Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Chinese Patent Medicine for Bones and Muscles Market Size by Region
8.3.1 Asia-Pacific Chinese Patent Medicine for Bones and Muscles Consumption Value by Region (2019-2030)
8.3.2 China Chinese Patent Medicine for Bones and Muscles Market Size and Forecast (2019-2030)
8.3.3 Japan Chinese Patent Medicine for Bones and Muscles Market Size and Forecast (2019-2030)
8.3.4 South Korea Chinese Patent Medicine for Bones and Muscles Market Size and Forecast (2019-2030)
8.3.5 India Chinese Patent Medicine for Bones and Muscles Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Chinese Patent Medicine for Bones and Muscles Market Size and Forecast (2019-2030)
8.3.7 Australia Chinese Patent Medicine for Bones and Muscles Market Size and Forecast (2019-2030)
9 South America
9.1 South America Chinese Patent Medicine for Bones and Muscles Consumption Value by Type (2019-2030)
9.2 South America Chinese Patent Medicine for Bones and Muscles Consumption Value by Application (2019-2030)
9.3 South America Chinese Patent Medicine for Bones and Muscles Market Size by Country
9.3.1 South America Chinese Patent Medicine for Bones and Muscles Consumption Value by Country (2019-2030)
9.3.2 Brazil Chinese Patent Medicine for Bones and Muscles Market Size and Forecast (2019-2030)
9.3.3 Argentina Chinese Patent Medicine for Bones and Muscles Market Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Chinese Patent Medicine for Bones and Muscles Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Chinese Patent Medicine for Bones and Muscles Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Chinese Patent Medicine for Bones and Muscles Market Size by Country
10.3.1 Middle East & Africa Chinese Patent Medicine for Bones and Muscles Consumption Value by Country (2019-2030)
10.3.2 Turkey Chinese Patent Medicine for Bones and Muscles Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Chinese Patent Medicine for Bones and Muscles Market Size and Forecast (2019-2030)
10.3.4 UAE Chinese Patent Medicine for Bones and Muscles Market Size and Forecast (2019-2030)
11 Market Dynamics
11.1 Chinese Patent Medicine for Bones and Muscles Market Drivers
11.2 Chinese Patent Medicine for Bones and Muscles Market Restraints
11.3 Chinese Patent Medicine for Bones and Muscles Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Chinese Patent Medicine for Bones and Muscles Industry Chain
12.2 Chinese Patent Medicine for Bones and Muscles Upstream Analysis
12.3 Chinese Patent Medicine for Bones and Muscles Midstream Analysis
12.4 Chinese Patent Medicine for Bones and Muscles Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Chinese Patent Medicine for Bones and Muscles Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Chinese Patent Medicine for Bones and Muscles Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Chinese Patent Medicine for Bones and Muscles Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Chinese Patent Medicine for Bones and Muscles Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Zhongheng Group Company Information, Head Office, and Major Competitors
Table 6. Zhongheng Group Major Business
Table 7. Zhongheng Group Chinese Patent Medicine for Bones and Muscles Product and Solutions
Table 8. Zhongheng Group Chinese Patent Medicine for Bones and Muscles Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Zhongheng Group Recent Developments and Future Plans
Table 10. Fangsheng Pharmaceutical Company Information, Head Office, and Major Competitors
Table 11. Fangsheng Pharmaceutical Major Business
Table 12. Fangsheng Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Solutions
Table 13. Fangsheng Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Fangsheng Pharmaceutical Recent Developments and Future Plans
Table 15. Yunnan Baiyao Group Company Information, Head Office, and Major Competitors
Table 16. Yunnan Baiyao Group Major Business
Table 17. Yunnan Baiyao Group Chinese Patent Medicine for Bones and Muscles Product and Solutions
Table 18. Yunnan Baiyao Group Chinese Patent Medicine for Bones and Muscles Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Beijing TRT Group Company Information, Head Office, and Major Competitors
Table 20. Beijing TRT Group Major Business
Table 21. Beijing TRT Group Chinese Patent Medicine for Bones and Muscles Product and Solutions
Table 22. Beijing TRT Group Chinese Patent Medicine for Bones and Muscles Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 23. Beijing TRT Group Recent Developments and Future Plans
Table 24. Pien Tze Huang Pharmaceutical Company Information, Head Office, and Major Competitors
Table 25. Pien Tze Huang Pharmaceutical Major Business
Table 26. Pien Tze Huang Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Solutions
Table 27. Pien Tze Huang Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 28. Pien Tze Huang Pharmaceutical Recent Developments and Future Plans
Table 29. BaiYunShan Pharmaceutical Company Information, Head Office, and Major Competitors
Table 30. BaiYunShan Pharmaceutical Major Business
Table 31. BaiYunShan Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Solutions
Table 32. BaiYunShan Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 33. BaiYunShan Pharmaceutical Recent Developments and Future Plans
Table 34. China Resources Sanjiu Company Information, Head Office, and Major Competitors
Table 35. China Resources Sanjiu Major Business
Table 36. China Resources Sanjiu Chinese Patent Medicine for Bones and Muscles Product and Solutions
Table 37. China Resources Sanjiu Chinese Patent Medicine for Bones and Muscles Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 38. China Resources Sanjiu Recent Developments and Future Plans
Table 39. Yiling Pharmaceutical Company Information, Head Office, and Major Competitors
Table 40. Yiling Pharmaceutical Major Business
Table 41. Yiling Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Solutions
Table 42. Yiling Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 43. Yiling Pharmaceutical Recent Developments and Future Plans
Table 44. Jumpcan Pharmaceutical Company Information, Head Office, and Major Competitors
Table 45. Jumpcan Pharmaceutical Major Business
Table 46. Jumpcan Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Solutions
Table 47. Jumpcan Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 48. Jumpcan Pharmaceutical Recent Developments and Future Plans
Table 49. Tasly Group Company Information, Head Office, and Major Competitors
Table 50. Tasly Group Major Business
Table 51. Tasly Group Chinese Patent Medicine for Bones and Muscles Product and Solutions
Table 52. Tasly Group Chinese Patent Medicine for Bones and Muscles Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 53. Tasly Group Recent Developments and Future Plans
Table 54. Buchang Pharmaceutical Company Information, Head Office, and Major Competitors
Table 55. Buchang Pharmaceutical Major Business
Table 56. Buchang Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Solutions
Table 57. Buchang Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 58. Buchang Pharmaceutical Recent Developments and Future Plans
Table 59. Sunflower Pharmaceutical Company Information, Head Office, and Major Competitors
Table 60. Sunflower Pharmaceutical Major Business
Table 61. Sunflower Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Solutions
Table 62. Sunflower Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 63. Sunflower Pharmaceutical Recent Developments and Future Plans
Table 64. Ginwa Enterprise Company Information, Head Office, and Major Competitors
Table 65. Ginwa Enterprise Major Business
Table 66. Ginwa Enterprise Chinese Patent Medicine for Bones and Muscles Product and Solutions
Table 67. Ginwa Enterprise Chinese Patent Medicine for Bones and Muscles Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 68. Ginwa Enterprise Recent Developments and Future Plans
Table 69. KPC Pharmaceutical Company Information, Head Office, and Major Competitors
Table 70. KPC Pharmaceutical Major Business
Table 71. KPC Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Solutions
Table 72. KPC Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 73. KPC Pharmaceutical Recent Developments and Future Plans
Table 74. Jiangsu Kanion Pharmaceutical Company Information, Head Office, and Major Competitors
Table 75. Jiangsu Kanion Pharmaceutical Major Business
Table 76. Jiangsu Kanion Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Solutions
Table 77. Jiangsu Kanion Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 78. Jiangsu Kanion Pharmaceutical Recent Developments and Future Plans
Table 79. Xintian Pharmaceutical Company Information, Head Office, and Major Competitors
Table 80. Xintian Pharmaceutical Major Business
Table 81. Xintian Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Solutions
Table 82. Xintian Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Xintian Pharmaceutical Recent Developments and Future Plans
Table 84. Henan Lingrui Pharmaceutical Company Information, Head Office, and Major Competitors
Table 85. Henan Lingrui Pharmaceutical Major Business
Table 86. Henan Lingrui Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Solutions
Table 87. Henan Lingrui Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 88. Henan Lingrui Pharmaceutical Recent Developments and Future Plans
Table 89. Global Chinese Patent Medicine for Bones and Muscles Revenue (USD Million) by Players (2019-2024)
Table 90. Global Chinese Patent Medicine for Bones and Muscles Revenue Share by Players (2019-2024)
Table 91. Breakdown of Chinese Patent Medicine for Bones and Muscles by Company Type (Tier 1, Tier 2, and Tier 3)
Table 92. Market Position of Players in Chinese Patent Medicine for Bones and Muscles, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 93. Head Office of Key Chinese Patent Medicine for Bones and Muscles Players
Table 94. Chinese Patent Medicine for Bones and Muscles Market: Company Product Type Footprint
Table 95. Chinese Patent Medicine for Bones and Muscles Market: Company Product Application Footprint
Table 96. Chinese Patent Medicine for Bones and Muscles New Market Entrants and Barriers to Market Entry
Table 97. Chinese Patent Medicine for Bones and Muscles Mergers, Acquisition, Agreements, and Collaborations
Table 98. Global Chinese Patent Medicine for Bones and Muscles Consumption Value (USD Million) by Type (2019-2024)
Table 99. Global Chinese Patent Medicine for Bones and Muscles Consumption Value Share by Type (2019-2024)
Table 100. Global Chinese Patent Medicine for Bones and Muscles Consumption Value Forecast by Type (2025-2030)
Table 101. Global Chinese Patent Medicine for Bones and Muscles Consumption Value by Application (2019-2024)
Table 102. Global Chinese Patent Medicine for Bones and Muscles Consumption Value Forecast by Application (2025-2030)
Table 103. North America Chinese Patent Medicine for Bones and Muscles Consumption Value by Type (2019-2024) & (USD Million)
Table 104. North America Chinese Patent Medicine for Bones and Muscles Consumption Value by Type (2025-2030) & (USD Million)
Table 105. North America Chinese Patent Medicine for Bones and Muscles Consumption Value by Application (2019-2024) & (USD Million)
Table 106. North America Chinese Patent Medicine for Bones and Muscles Consumption Value by Application (2025-2030) & (USD Million)
Table 107. North America Chinese Patent Medicine for Bones and Muscles Consumption Value by Country (2019-2024) & (USD Million)
Table 108. North America Chinese Patent Medicine for Bones and Muscles Consumption Value by Country (2025-2030) & (USD Million)
Table 109. Europe Chinese Patent Medicine for Bones and Muscles Consumption Value by Type (2019-2024) & (USD Million)
Table 110. Europe Chinese Patent Medicine for Bones and Muscles Consumption Value by Type (2025-2030) & (USD Million)
Table 111. Europe Chinese Patent Medicine for Bones and Muscles Consumption Value by Application (2019-2024) & (USD Million)
Table 112. Europe Chinese Patent Medicine for Bones and Muscles Consumption Value by Application (2025-2030) & (USD Million)
Table 113. Europe Chinese Patent Medicine for Bones and Muscles Consumption Value by Country (2019-2024) & (USD Million)
Table 114. Europe Chinese Patent Medicine for Bones and Muscles Consumption Value by Country (2025-2030) & (USD Million)
Table 115. Asia-Pacific Chinese Patent Medicine for Bones and Muscles Consumption Value by Type (2019-2024) & (USD Million)
Table 116. Asia-Pacific Chinese Patent Medicine for Bones and Muscles Consumption Value by Type (2025-2030) & (USD Million)
Table 117. Asia-Pacific Chinese Patent Medicine for Bones and Muscles Consumption Value by Application (2019-2024) & (USD Million)
Table 118. Asia-Pacific Chinese Patent Medicine for Bones and Muscles Consumption Value by Application (2025-2030) & (USD Million)
Table 119. Asia-Pacific Chinese Patent Medicine for Bones and Muscles Consumption Value by Region (2019-2024) & (USD Million)
Table 120. Asia-Pacific Chinese Patent Medicine for Bones and Muscles Consumption Value by Region (2025-2030) & (USD Million)
Table 121. South America Chinese Patent Medicine for Bones and Muscles Consumption Value by Type (2019-2024) & (USD Million)
Table 122. South America Chinese Patent Medicine for Bones and Muscles Consumption Value by Type (2025-2030) & (USD Million)
Table 123. South America Chinese Patent Medicine for Bones and Muscles Consumption Value by Application (2019-2024) & (USD Million)
Table 124. South America Chinese Patent Medicine for Bones and Muscles Consumption Value by Application (2025-2030) & (USD Million)
Table 125. South America Chinese Patent Medicine for Bones and Muscles Consumption Value by Country (2019-2024) & (USD Million)
Table 126. South America Chinese Patent Medicine for Bones and Muscles Consumption Value by Country (2025-2030) & (USD Million)
Table 127. Middle East & Africa Chinese Patent Medicine for Bones and Muscles Consumption Value by Type (2019-2024) & (USD Million)
Table 128. Middle East & Africa Chinese Patent Medicine for Bones and Muscles Consumption Value by Type (2025-2030) & (USD Million)
Table 129. Middle East & Africa Chinese Patent Medicine for Bones and Muscles Consumption Value by Application (2019-2024) & (USD Million)
Table 130. Middle East & Africa Chinese Patent Medicine for Bones and Muscles Consumption Value by Application (2025-2030) & (USD Million)
Table 131. Middle East & Africa Chinese Patent Medicine for Bones and Muscles Consumption Value by Country (2019-2024) & (USD Million)
Table 132. Middle East & Africa Chinese Patent Medicine for Bones and Muscles Consumption Value by Country (2025-2030) & (USD Million)
Table 133. Global Key Players of Chinese Patent Medicine for Bones and Muscles Upstream (Raw Materials)
Table 134. Global Chinese Patent Medicine for Bones and Muscles Typical Customers
List of Figures
Figure 1. Chinese Patent Medicine for Bones and Muscles Picture
Figure 2. Global Chinese Patent Medicine for Bones and Muscles Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Chinese Patent Medicine for Bones and Muscles Consumption Value Market Share by Type in 2023
Figure 4. Oral
Figure 5. Topical
Figure 6. Others
Figure 7. Global Chinese Patent Medicine for Bones and Muscles Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 8. Chinese Patent Medicine for Bones and Muscles Consumption Value Market Share by Application in 2023
Figure 9. Hospital Picture
Figure 10. Pharmacy Picture
Figure 11. Others Picture
Figure 12. Global Chinese Patent Medicine for Bones and Muscles Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Chinese Patent Medicine for Bones and Muscles Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Market Chinese Patent Medicine for Bones and Muscles Consumption Value (USD Million) Comparison by Region (2019 VS 2023 VS 2030)
Figure 15. Global Chinese Patent Medicine for Bones and Muscles Consumption Value Market Share by Region (2019-2030)
Figure 16. Global Chinese Patent Medicine for Bones and Muscles Consumption Value Market Share by Region in 2023
Figure 17. North America Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030) & (USD Million)
Figure 18. Europe Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030) & (USD Million)
Figure 19. Asia-Pacific Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030) & (USD Million)
Figure 20. South America Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030) & (USD Million)
Figure 21. Middle East & Africa Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030) & (USD Million)
Figure 22. Company Three Recent Developments and Future Plans
Figure 23. Global Chinese Patent Medicine for Bones and Muscles Revenue Share by Players in 2023
Figure 24. Chinese Patent Medicine for Bones and Muscles Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2023
Figure 25. Market Share of Chinese Patent Medicine for Bones and Muscles by Player Revenue in 2023
Figure 26. Top 3 Chinese Patent Medicine for Bones and Muscles Players Market Share in 2023
Figure 27. Top 6 Chinese Patent Medicine for Bones and Muscles Players Market Share in 2023
Figure 28. Global Chinese Patent Medicine for Bones and Muscles Consumption Value Share by Type (2019-2024)
Figure 29. Global Chinese Patent Medicine for Bones and Muscles Market Share Forecast by Type (2025-2030)
Figure 30. Global Chinese Patent Medicine for Bones and Muscles Consumption Value Share by Application (2019-2024)
Figure 31. Global Chinese Patent Medicine for Bones and Muscles Market Share Forecast by Application (2025-2030)
Figure 32. North America Chinese Patent Medicine for Bones and Muscles Consumption Value Market Share by Type (2019-2030)
Figure 33. North America Chinese Patent Medicine for Bones and Muscles Consumption Value Market Share by Application (2019-2030)
Figure 34. North America Chinese Patent Medicine for Bones and Muscles Consumption Value Market Share by Country (2019-2030)
Figure 35. United States Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030) & (USD Million)
Figure 36. Canada Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030) & (USD Million)
Figure 37. Mexico Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030) & (USD Million)
Figure 38. Europe Chinese Patent Medicine for Bones and Muscles Consumption Value Market Share by Type (2019-2030)
Figure 39. Europe Chinese Patent Medicine for Bones and Muscles Consumption Value Market Share by Application (2019-2030)
Figure 40. Europe Chinese Patent Medicine for Bones and Muscles Consumption Value Market Share by Country (2019-2030)
Figure 41. Germany Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030) & (USD Million)
Figure 42. France Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030) & (USD Million)
Figure 43. United Kingdom Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030) & (USD Million)
Figure 44. Russia Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030) & (USD Million)
Figure 45. Italy Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030) & (USD Million)
Figure 46. Asia-Pacific Chinese Patent Medicine for Bones and Muscles Consumption Value Market Share by Type (2019-2030)
Figure 47. Asia-Pacific Chinese Patent Medicine for Bones and Muscles Consumption Value Market Share by Application (2019-2030)
Figure 48. Asia-Pacific Chinese Patent Medicine for Bones and Muscles Consumption Value Market Share by Region (2019-2030)
Figure 49. China Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030) & (USD Million)
Figure 50. Japan Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030) & (USD Million)
Figure 51. South Korea Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030) & (USD Million)
Figure 52. India Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030) & (USD Million)
Figure 53. Southeast Asia Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030) & (USD Million)
Figure 54. Australia Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030) & (USD Million)
Figure 55. South America Chinese Patent Medicine for Bones and Muscles Consumption Value Market Share by Type (2019-2030)
Figure 56. South America Chinese Patent Medicine for Bones and Muscles Consumption Value Market Share by Application (2019-2030)
Figure 57. South America Chinese Patent Medicine for Bones and Muscles Consumption Value Market Share by Country (2019-2030)
Figure 58. Brazil Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030) & (USD Million)
Figure 59. Argentina Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030) & (USD Million)
Figure 60. Middle East & Africa Chinese Patent Medicine for Bones and Muscles Consumption Value Market Share by Type (2019-2030)
Figure 61. Middle East & Africa Chinese Patent Medicine for Bones and Muscles Consumption Value Market Share by Application (2019-2030)
Figure 62. Middle East & Africa Chinese Patent Medicine for Bones and Muscles Consumption Value Market Share by Country (2019-2030)
Figure 63. Turkey Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030) & (USD Million)
Figure 64. Saudi Arabia Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030) & (USD Million)
Figure 65. UAE Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030) & (USD Million)
Figure 66. Chinese Patent Medicine for Bones and Muscles Market Drivers
Figure 67. Chinese Patent Medicine for Bones and Muscles Market Restraints
Figure 68. Chinese Patent Medicine for Bones and Muscles Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Chinese Patent Medicine for Bones and Muscles Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Zhongheng Group Fangsheng Pharmaceutical Yunnan Baiyao Group Beijing TRT Group Pien Tze Huang Pharmaceutical BaiYunShan Pharmaceutical China Resources Sanjiu Yiling Pharmaceutical Jumpcan Pharmaceutical Tasly Group Buchang Pharmaceutical Sunflower Pharmaceutical Ginwa Enterprise KPC Pharmaceutical Jiangsu Kanion Pharmaceutical Xintian Pharmaceutical Henan Lingrui Pharmaceutical
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
-
- Digging deeper into global industry information and providing market strategies.Contact Us >>